BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2001

View Archived Issues

Second-quarter progress reported in Sanochemia projects

Read More

Synthetic peptide bundles F-actin in vitro and in situ; available for licensing

Read More

KW-7158 to enter phase II trials in Europe for treatment of urinary incontinence

Read More

Gilead presents data characterizing resistance profile of tenofovir DF

Read More

Antares Pharma delivery technology utilized in new testosterone gel for FSD

Read More

GM-611 improves delayed gastric emptying in patients with gastroparesis

Read More

DDW presentation reports rapid vascular shutdown in tumor-bearing rats treated with AC-7700

Read More

Zomig-ZMT now available in U.S. for treatment of migraine

Read More

MedImmune expands phase II development of MEDI-507 to include Europe

Read More

Prostanoid EP1 antagonist ZD-6416 as a novel therapy for common painful disorder

Read More

Preliminary phase I data for Revimid show activity against solid tumors, good safety

Read More

Bone loss and turnover inhibited by lasofoxifene in OVX primates, without uterine hypertrophy

Read More

Guilford's sNDA for Gliadel Wafer accepted by FDA

Read More

IBMS/ECTS 2001 news: FC-1271a is a promising new SERM for postmenopausal women

Read More

Viragen and NIH begin preclinical studies of anti-Notch-1 monoclonal antibodies

Read More

FDA advisory committee votes in favor of Xyrem's efficacy for cataplexy

Read More

New bisphosphonate inhibits two enzymes in the mevalonate pathway

Read More

Phytopharmaceutical DA-9601 prevents development of pancreatic fibrosis

Read More

ConjuChem highlights Q2 developments

Read More

Somatostatin-mediated targeting of DNA into tumor cells

Read More

NOD2 mutants associated with Crohn's disease

Read More

Cannabinoids a focus of research at U. of Connecticut

Read More

Novel Taisho compounds useful for immune and allergic disorders

Read More

Microtubule polymerization enhancers for cancer patented by Novartis and Scripps

Read More

Pyridine-based inhibitors of collagen production emerge from R&D at Otsuka

Read More

Aventis presents new series of anticoagulant/antithrombotic compounds

Read More

New 2-alkoxybenzene tachykinin antagonists from Sankyo with good oral activity

Read More

Derivatives of UCS-1025 synthesized at Kyowa Hakko with antibacterial and antitumor activity

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 12, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing